Daniel Mollenkamp || 4th December 2017 || News analysis || Health and science | Nicotine | Policy and Politics | Regulation and Legislation | Geographies: North America United States
The US Food and Drug Administration (FDA) has extended the deadline for comments on Philip Morris International’s (PMI’s) modified risk tobacco product application (MRTPA) for its IQOS heated tobacco device and Heatstick consumables.
Are you already a subscriber? login here Enjoy free subscription access Get access to premium content that is normally only available for subscribers. For the duration of a week, you can read our news analysis, identify market trends and understand upcoming changes in the industry, which will enable you to get ahead of your competitors. Benefits of subscription plans: Stay informed of any legal and market change in the sector that impacts your organization Maximise resources by getting market and legal data analysis daily in one place Make smart decisions by understanding how the regulatory and market landscape evolves Anticipate risks in your decisions by monitoring regulatory changes that impact your organization